BPOM Grants GMP Certificate for Merah Putih Vaccine Production

18 August 2021 19:15 WIB

Researchers work in a research room of the Merah Putih vaccine at the Bio Farma Office in Bandung, Thursday, August 12, 2020. ANTARA/Dhemas Reviyanto

TEMPO.CO, JakartaThe Food and Drug Monitoring Agency (BPOM) granted a certificate of Good Manufacturing Practices (GMP) Fill and Finish Facility for the production of homegrown Covid-19 vaccine candidate to PT Biotis Pharmaceuticals.

The vaccine developed by PT Biotis in collaboration with Airlangga University or Unair is part of the Merah Putih vaccine program being prepared by the government.

BPOM head Penny Lukito said her side carried out various assistance ranging from facility design, inspection, desk consultation, inspection, up to repairment, in order to issue the GMP certificate.

“This is not easy,” said Penny in an online press conference after the GMP certificate handover on Wednesday, August 18.

Penny said PT Biotis is the second-largest human vaccine production industry in Indonesia after state-run pharmacy Bio Farma. Of the six vaccine candidates being developed by a number of parties, the Merah Putih vaccine developed by Unair showed the most advanced development.

The first phase pre-clinical trial of the inactivated vaccine on transgenic animals has been completed. At present, the second phase trial on macaques is underway.

“Hopefully, the Merah Putih vaccine produced by Unair and Biotis [can be mass produced] in the first semester of 2022, if it goes according to the plan,” said Penny.

Read: Eijkman: Merah Putih Vaccine to Be Tested Against Delta Variant

EGI ADYATAMA



BPOM Assures All Domestically Made COVID Vaccines are Halal

7 hari lalu

BPOM Assures All Domestically Made COVID Vaccines are Halal

BPOM has confirmed that all three domestic manufacturers of COVID-19 vaccines have obtained halal certificates from the concerned authority.


Indonesia's Latest Flying Rule Mandates Passengers to Have Booster Shots

16 hari lalu

Indonesia's Latest Flying Rule Mandates Passengers to Have Booster Shots

The requirement for air passengers to have received a booster shot will be applied in September.


BPOM Comments on Singapore Recalling ABC Sauce Products

27 hari lalu

BPOM Comments on Singapore Recalling ABC Sauce Products

The BPOM commented on Singapore's food agency or SFA which recalled two ABC sauce products.


Erick Thohir Claims Domestic Vaccine Indovac Has High Efficacy, Halal

33 hari lalu

Erick Thohir Claims Domestic Vaccine Indovac Has High Efficacy, Halal

SOE Minister Erick Thohir disclosed that based on the clinical trial, homegrown COVID-19 vaccine developed by Bio Farma, Indovac, has high efficacy.


Booster Jab Required for Long-distance Train Travelers Starting August 30

38 hari lalu

Booster Jab Required for Long-distance Train Travelers Starting August 30

Passengers of long-distance trains aged 18 years and above are required to get a booster shot starting Tuesday, August 30.


Australia Researchers Strive for "Universal" Vaccine for All COVID-19 Variants

47 hari lalu

Australia Researchers Strive for "Universal" Vaccine for All COVID-19 Variants

Australian medical researchers are working towards creating a booster vaccine capable of dealing with the ever-growing array of COVID-19 variants.


Covid-19 Vaccine Fourth Dose Rollout After Third Dose Coverage Touches 50%: Health Ministry

2 Agustus 2022

Covid-19 Vaccine Fourth Dose Rollout After Third Dose Coverage Touches 50%: Health Ministry

Health Ministry said that the fourth dose of Covid-19 vaccine will be provided to the general public once the coverage of the third dose reaches 50%


Indonesia Producing mRNA COVID-19 Vaccine with China's Technology

28 Juli 2022

Indonesia Producing mRNA COVID-19 Vaccine with China's Technology

Indonesia is set to produce a COVID-19 vaccine using messenger RNA (mRNA) technology, which is similar to Pfizer and Moderna.


Health Ministry Discusses Second Booster Dose of COVID-19 Vaccine

22 Juli 2022

Health Ministry Discusses Second Booster Dose of COVID-19 Vaccine

Health Ministry is discussing the distribution of the second booster dose of the COVID-19 vaccine.


Indonesia Allows Emergency Use of Paxlovid; Reportedly 90% Effective as Covid-19 Drug

19 Juli 2022

Indonesia Allows Emergency Use of Paxlovid; Reportedly 90% Effective as Covid-19 Drug

Paxlovid is produced by Pfizer as a drug claimed to have up to 90 percent effectiveness in preventing severe COVID-19 symptoms.